The long-term use of selective serotonin reuptake inhibitors (SSRIs) raises serotonin levels in the brain enough to deactivate signaling pathways that increase bone formation, providing the solution to a long-term riddle – why SSRIs, which increase the availability of serotonin in the brain, increase fracture risk even though brain serotonin signaling increases bone formation.